Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Background

Dr. Sarah M. Cork is a member of the litigation group in Fish’s Washington D.C. office. Her practice focuses primarily on patent litigation in the life sciences, including small-molecule and biologic pharmaceuticals and biomedical devices. As a litigator who also holds a Ph.D. in Neuroscience, she brings highly sophisticated technical expertise to her cases, enabling her to learn her clients’ technology quickly and at a deep level. She has significant experience with issues relating to patent inventorship. Before joining Fish, Dr. Cork worked on patent litigation and interferences at another D.C. firm.

Dr. Cork maintains an active pro bono practice and regularly appears in court on behalf of low-income individuals. She has assisted clients with a variety of legal issues, including housing conditions, child custody, and immigration.

Dr. Cork’s doctoral dissertation research evaluated novel anti-angiogenic proteolytic and cell signaling mechanisms as therapeutic targets for glioblastoma multiforme. While at Michigan Law, she taught multiple semesters as a graduate student instructor for an undergraduate Cell Biology capstone course. Dr. Cork also volunteers with the Rare Genomics Institute, a non-profit organization devoted to supporting individuals with rare genetic diseases.

Education

J.D., University of Michigan 2014
​cum laude


Ph.D., Emory University 2011
Neuroscience


B.S., Duke University 2005
Biology; Biological Anthropology and Anatomy
​with distinction

Admissions

  • Georgia 2014
  • District of Columbia
  • U.S. Court of Appeals for the Federal Circuit

Memberships & Affiliations

​Giles S. Rich Inn of Court, Co-administrator, 2018-2019

Other Distinctions

Honors & Awards

Selected as a Washington, D.C. Rising Star by Super Lawyers (2018).

Editor in Chief, Michigan Telecommunications and Technology Law Review (2013-2014)

Dean’s Scholar (2011-2014)

James B. Rast Memorial Award for achievement in Organismal Biology (2005)

Selected Publications

An End-Run Around Myriad And ‘Product Of Nature’ Problem,” Law360, Co-authored with Janis Fraser (September 2016).

S.M. Cork et al., A furin/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1, ONCOGENE 31(50):5144-52 (2012).​

S.M. Cork & Erwin G. Van Meir, Emerging roles for the BAI1 protein family in the regulation of phagocytosis, synaptogenesis, neurovasculature and tumor development, JOURNAL OF MOLECULAR MEDICINE. 89(8):743–52 (2011).

B. Kaur, S.M. Cork, et al. Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism, CANCER RESEARCH 69(3):1212–20 (2009).​

What's trending with Sarah